Federal contract award
75N95025P00350
REVVITY HEALTH SCIENCES, INC:1106024 [25-004016] H] DAMGO, [3H] ENKEPHALIN, AND [3H] U69,593 IN ORDER TO PERFORM ONGOING BINDING EXPERIMENTS TO STUDY NEWLY EMERGING DRUGS OF ABUSE.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIDA |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6810 — Chemicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $11.3K |
| Current contract value | $11.3K |
| Potential contract value / ceiling | $11.3K |
| Start date | Aug 21, 2025 |
| Current end date | Oct 31, 2025 |
| Potential end date | Oct 31, 2025 |
| Latest award activity | Aug 25, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 25, 2025 | 0 | $11.3K | REVVITY HEALTH SCIENCES, INC:1106024 [25-004016] H] DAMGO, [3H] ENKEPHALIN, AND [3H] U69,593 IN ORDER TO PERFORM ONGOING BINDING EXPERIMENTS TO STUDY NEWLY EMERGING DRUGS OF ABUSE. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.